Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin domain containing 9 pseudogene (TXNDC9 pseudogene, LOC285453, ENSG00000227040) is a classified pseudogene located on chromosome 4. Pseudogenes are gene variants rendered non-functional by mutations such as frameshifts, premature stop codons, or deletions that prevent them from encoding functional proteins[3][1]. The TXNDC9 pseudogene resembles its parent, Thioredoxin domain containing 9 (TXNDC9), but lacks coding ability and known biological activity. No evidence supports its use in drug development, disease association, biomarker identification, or as a receptor, transporter, enzyme, or therapeutic target[1][3][4]. Pseudogenes are noted for their similarity to protein-coding genes but are generally considered genomic fossils, sometimes involved in regulatory or evolutionary processes, but typically not directly relevant for biomedical targeting or drug discovery[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin domain containing 9 pseudogene (TXNDC9 pseudogene).